A Review of guidelines for dyslipidemia in children and adolescents

Wisconsin Medical Journal

Volumn 111, Issue 6, 2012, Pages 274-281

  Peterson, Amy L ^a   McBride, Patrick E ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHILD CARE; CHOLESTEROL BLOOD LEVEL; DIABETES MELLITUS; DYSLIPIDEMIA; EARLY INTERVENTION; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILIAL HYPERLIPEMIA; FAMILY HISTORY; GENETIC RISK; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; OBESITY; PATIENT IDENTIFICATION; PATIENT MONITORING; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; RISK REDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; ADOLESCENT; ADULT; CHILD; RISK FACTOR; UNITED STATES;

ADOLESCENT; CHILD; DYSLIPIDEMIAS; HUMANS; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; UNITED STATES; YOUNG ADULT;

MLCS; MLOWN;

EID: 84874795709     PISSN: 10981861     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Ose L. An update on familial hypercholesterolemia. Ann Med. 1999; 31(Suppl 1):13-18.
2. Leren TP, Finborud TH, Manshaus TE, Ose L, Berge KE. Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening. Community Genet. 2008;11(1):26-35.
3. Ose L. Diagnostic, clinical, and therapeutic aspects of familial hypercholesterolemia in children. Semin Vasc Med. 2004;4(1):51-57.
4. Smoak CG, Burke GL, Webber LS, Harsha DW, Srinivasan SR, Berenson GS. Relation of obesity to clustering of cardiovascular disease risk factors in children and young adults: the Bogalusa Heart Study. Am J Epidemiol. 1978;125(3):364-372.
5. Ritchie S, Murphy E, Ice C, et al. Universal versus targeted blood cholesterol screening among youth: the CARDIAC project. Pediatrics. 2010;126(2):260-265.
6. Eissa MA, Wen E, Mihalopoulos NL, et al. Evaluation of AAP guidelines for cholesterol screening in youth: Project HeartBeat! Am J Prev Med. 2009;37(1 Suppl):S71-S77.
7. Kavey RW, Simons-Morton DG, de Jesus JM, ed. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report. Pediatrics. 2011;128(Suppl 5):S213-256.
8. Haney EM, Huffman LH, Bougatsos C, Freeman M, Steiner RD, Nelson HD. Screening and treatment for lipid disorders in children and adolescents: systematic evidence review for the US Preventive Services Task Force. Pediatrics. 2007;120(1):e189-e214.
9. Weiss R, Dziura J, Burgert TS, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350(23):2362-2374.
10. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States 1999-2004. JAMA. 2006;295(13)1549-1555.
11. Lifshitz F. Obesity in children. J Clin Res Pediatr Endocrinol. 2008; 1(2):53-60.
12. Kwiterovich PO Jr. Recognition and management of dyslipidemia in children and adolescents. J Clin Endocrinol Metab. 2008;93(11):4200-4209.
13. Mantel-Teeuwisse AK, Verschuren WMM, Klungel OH, Kromhout D, Lindemans AD, Avorn J, Porsius AJ, de Boer A. Undertreatment of hypercholesterolaemia: a population-based study. Br J Clin Pharmacol. 2003;55(4):389-397.
14. Hopkins PN, Toth PP, Ballantyne CM, Rader DJ. Familial hypercholesterolemias: prevalence, genetics, diagnosis, and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol. 2011;5(3 suppl):S9-S17.
15. Gidding SS, Bao W, Srinivasan SR, Berenson GS. Effects of secular trends in obesity on coronary risk factors in children: the Bogalusa Heart Study. J Pediatr. 1995;127(6):868-874.
16. Kikuchi DA, Srinivasan SR, Harsha DW, Webber LS, Sellers TA, Berenson GS. Relation of serum lipoprotein lipids and apolipoproteins to obesity in children: the Bogalusa Heart Study. Prev Med. 1992;21(2):177-190.
17. Wattigney WA, Harsha DW, Srinivasan SR, Webber LS, Berenson GS. Increasing impact of obesity on serum lipids and lipoproteins in young adults: the Bogalusa Heart Study. Arch Intern Med. 1991;151(10):2017-2022.
18. Freedman DS, Mei Z, Srinivasan SR, Bereson GS, Dietz WH. Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa Heart Study. J Pediatr. 2007;150(1):12-17.
19. Sinaiko AR, Donahue RP, Jacobs DR, Jr., Prineas RJ. Relation of weight and rate of increase in weight during childhood and adolescence to body size, blood pressure, fasting insulin, and lipids in young adults: the Minneapolis Children's Blood Pressure Study. Circulation. 1999;99(11):1471-1476.
20. National Heart Lung and Blood Institute. Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents. Report of the Expert Panel. December 2011. http://www.nhlbi.nih.gov/guidelines/cvd_ped/index.htm. Accessed October 26, 2012.
21. Kwiterovich PO, Barton BA, McMahon RP, et al. Effects of diet and sexual maturation on low-density lipoprotein cholesterol during puberty: the Dietary Intervention Study in Children (DISC). Circulation. 1997;96(8):2526-2533.
22. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: the Bogalusa Heart Study. N Engl J Med. 1998;338(23):1650-1656.
23. McGill HC Jr, McMahan CA, Zieske AW, Sloop GD, Walcott JV, Troxclair DA, Malcom GT, Tracy RE, Oalmann MC, Strong JP.Associations of coronary heart disease risk factors with the intermediate lesion of atherosclerosis in youth: the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb Vasc Biol. 2000;20(8):1998-2004.
24. McGill HC Jr, McMahan CA, Herderick EE, Tracy RE, Malcom GT, Zieske AW, Strong J P. Effects of coronary heart disease risk factors on atherosclerosis of selected regions of the aorta and right coronary artery. PDAY Research Group. Pathobiological Determinants of Atherosclerosis in Youth. Arterioscler Thromb Vasc Biol. 2000;20(3):836-845.
25. McGill HC, McMaham A, Gidding SS. Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. Circulation. 2008;117(9):1216-1227.
26. Juonala M, Vikari J, Ronnemaa T, et al. Association of dyslipidemias from childhood to adulthood with carotid intima-media thickness, elasticity and brachial flow-mediated dilatation in adulthood. Arterioscler Thromb Vasc Biol. 2008;28(5):1012-1017.
27. Haney EM, Huffman LH, Bougatsos C, Freeman M, Steiner RD, Nelson HD. Screening and treatment for lipid disorders in children and adolescents: systematic evidence review for the US Preventive Services Task Force. Pediatrics. 2007;120(1):e189-e214.
28. McGill HC, Jr, McMahan CA, Gidding SS. Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study. Circulation. 2008;117(9):1216-1227.
29. Stamler J, Stamler R, Neaton JD, et al. Low risk-factor profile and long-term cardiovascular and non-cardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women. JAMA. 1999;282(21):2012-2018.
30. Raitakari OT, Ronnemaa T, Jarvisalo MJ, et al. Endothelial function in healthy 11-year-old children after dietary intervention with onset in infancy: the Special Turku coronary Risk factor Intervention Project for Children (STRIP). Circulation. 2005;112(24):3786-3794.
31. Rodenburg J, Vissers MN, Wiegman A, et al. Statin treatment in children with familial hypercholesterolemia: the younger the better. Circulation. 2007;116(6):664-668.
32. Daniels SR, Greer FR, and the Committee on Nutrition. Lipid screening and cardiovascular health in childhood. Pediatrics. 2008;122(1):198-208.
33. Wiegman A, Hutten BA, de Groot E, et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA. 2004;292(3):331-337.
34. Dennison BA, Kikuchi DA, Srinivasan SR, Webber LS, Berenson GS. Parental history of cardiovascular disease as an indication for screening for lipoprotein abnormalities in children. J Pediatr. 1989;115(2):186-194.
35. Griffin TC, Christoffel KK, Binns HJ, McGuire PA. Family history evaluation as a predictive screen for childhood hypercholesterolemia. Pediatric Practice Research Group. Pediatrics. 1989;84(2):365-373.
36. Starc TJ, Belamarich PF, Shea S, et al. Family history fails to identify many children with severe hypercholesterolemia. Am J Dis Child. 1991;145(1):61-64.
37. Morris JK, Wald DS, Wald NJ. The evaluation of cascade testing for familial hy-percholesterolemia. Am J Med Genet A. 2012;158A(1):78-84.